While alpha-fetoprotein (AFP) is the most widely used tumour marker for hepatocellular carcinoma (HCC) surveillance, experience with des-gamma-carboxyprothrombin (DCP) is limited. This evidence concerns the gene AFP and hepatocellular carcinoma.